check_circleStudy Completed

Fever, Migraine, Pain

Bayer Identifier:

14623

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

2010-020235-39

EU CT Number:

Not Available
BAY81-8781, Single dose escalation study

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

18 - 45 Years
  • -

  • -

Trial summary

Enrollment Goal
38
Trial Dates
July 2010 - December 2010
Phase
Phase 1
Could I Receive a placebo
N/A
Products
Aspirin (Acetylsalicylic Acid, BAY81-8781)
Accepts Healthy Volunteer
N/A

Where to participate

StatusInstitutionLocation
Completed
Bayer HealthCareWuppertal, 42096, Germany

Trial design

Single dose escalation study to investigate safety, tolerability and pharmacokinetics of increasing inhalative doses of Acetylsalicylic Acid (BAY 81-8781) in a randomized, singleblind, group-comparison design in healthy male subjects
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.